Purchase Order 75N95024P00283
Award Date
5/21/24
Potential Completion Date
5/20/25
Potential Value
$64K
Federal Agency
National Institute on Drug Abuse
Awardee
Pelago Bioscience AB
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sweden
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $109,392.00 contract is for compound testing services, including plasma protein binding studies, PXR and AhR activation studies, and CYP inhibition assays on various small molecule compounds. This work supports NIDA's mission to seek fundamental...
This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...
This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...
This is a $75,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Human Metabolome Technologies America, Inc., a self-certified small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics profiling services, which includes conducting metabolomic assays, lipidomic analyses, and targeted metabolomics on samples related to various areas of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,791.66 firm fixed-price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, for the delivery of a Custom SimplePlex Assay Panel (SPCKE-PS-010046 SPCKE-08). Performance will take place in Baltimore, Maryland through September 2024. The contract calls for Proteinsimple to provide their proprietary assay panel and related services...
<p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.</p>
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,656.84 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation. The contract is to provide Lindsay Kryszak with a custom SimplePlex cartridge kit for 32 samples to support protein analysis. Performance will occur in Baltimore, Maryland over a one year period from December 2023 through December 2024. No subcontractors or set aside designations...
This is a $100,000.00 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for targeted metabolomics analyses of human brain tissue samples, with a period of performance running until November 15, 2019. No set-aside designation was used for this award. Human Metabolome...